Â¥
4.84
Oct 18
New Key Statistics Module, Z-Score and F-Score
SZSE:300391 Key Ratios
Market Cap ¥ M | 1,601.04 |
Enterprise Value ¥ M | 2,473.05 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 40.33 |
Price/Sales | 2.09 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 795.00 |
EPS (TTM) ¥ | -2.10 |
Beneish M-Score | -3.15 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -3,029.90 |
EV-to-EBIT | -3.13 |
EV-to-EBITDA | -3.13 |
PEG | -- |
Shares Outstanding M | 350.34 |
Net Margin (%) | -92.31 |
Operating Margin % | 1.78 |
Pre-tax Margin (%) | -110.57 |
Quick Ratio | 1.00 |
Current Ratio | 1.03 |
ROA % (ttm) | -21.02 |
ROE % (ttm) | -198.75 |
ROIC % (ttm) | 0.70 |
Dividend Yield % | -- |
Altman Z-Score | -0.63 |
SZSE:300391 Number of Guru Trades
SZSE:300391 Volume of Guru Trades
Gurus Latest Trades with SZSE:300391
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300391 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Changjiang Pharmaceutical Group Co Ltd Insider Transactions
No Available Data